Market Place
Sourcing Support
Odyssey and Terray Therapeutics Collaborate on 1st-in-Class Therapy
28 Oct 2024 //
BUSINESSWIRE
Odyssey Therapeutics Shares Data on RIPK2 Inhibitor at ACG
27 Oct 2024 //
BUSINESSWIRE
Odyssey Therapeutics Adds Two Biopharma Veterans To Board
02 Oct 2024 //
BUSINESSWIRE
Odyssey Therapeutics Announces Scientific Advisory Board
27 Sep 2024 //
BUSINESSWIRE
Odyssey Therapeutics Appoints Dr. William Roush As EVP
01 Aug 2024 //
BUSINESSWIRE
Odyssey Announces Collab to Advance AI-Driven Small Molecule Drug Discovery
04 Apr 2024 //
BUSINESSWIRE
Odyssey Appoints Julie Clauss as COO and Butler as SVP, Head of Chemistry
02 Apr 2024 //
BUSINESSWIRE
Odyssey Therapeutics Announces $101 Million Series C Financing
05 Dec 2023 //
BUSINESSWIRE
Odyssey raises epic $101M to push programs off to clinical sea
05 Dec 2023 //
FIERCE BIOTECH
Odyssey Therapeutics to Present Data for Three Immunology Programs
09 Nov 2023 //
BUSINESSWIRE
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer
04 Oct 2023 //
BUSINESSWIRE
Odyssey Expands Management Team with Key Appointments in R&D and Strategy
09 Nov 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.